Clinical Trial Update: Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating botulinum toxin A (NT 201) dose groups for safety and duration of effect in treating glabellar frown lines; study completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• To Severe Glabellar Frown Lines

Drugs mentioned

• NT 201

Snippet

Sponsor: Merz Aesthetics GmbH | Conditions: Moderate to Severe Glabellar Frown Lines | Phase 2 | Status: COMPLETED | Results posted: 2023-10-04